selenomethionine (SLM) - Holden Comprehensive Cancer Center, The University of Iowa
Keytruda (pembrolizumab) - Merck (MSD)
Inlyta (axitinib) - Pfizer
http://clinicaltrials.gov/ct2/show/NCT05363631
 
Dec 11, 2025
 
Next